Net sales grew 4.5% year-over-year to SEK 200m, with strong performance in the Americas offsetting declines in EMEA and APAC. Gross margin improved to 70%, while EBITDA margin fell to 27% due to CEO transition costs. The BMA Application launch and ongoing innovation support a positive outlook.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.